Clinical trial
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
NCT06971276 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 3, 2024
- Completion date
- December 31, 2025
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anal dysplasia